{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:52:12Z","timestamp":1764402732407,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["BMBF 01 EO 0803","BMBF 01EO1303"],"award-info":[{"award-number":["BMBF 01 EO 0803","BMBF 01EO1303"]}]},{"name":"Monika-Kutzner foundation"},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P26421"],"award-info":[{"award-number":["P26421"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00277-016-2788-6","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T20:08:21Z","timestamp":1471637301000},"page":"1979-1988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia"],"prefix":"10.1007","volume":"95","author":[{"given":"Andrea","family":"Haerzschel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Catusse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Hutterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Paunovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Zirlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Eibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Krenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja N.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"issue":"19","key":"2788_CR1","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117(19):5019\u20135032. doi: 10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"issue":"10","key":"2788_CR2","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","volume":"109","author":"CI Mockridge","year":"2007","unstructured":"Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK (2007) Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood 109(10):4424\u20134431. doi: 10.1182\/blood-2006-11-056648","journal-title":"Blood"},{"issue":"1","key":"2788_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","volume":"112","author":"M Muzio","year":"2008","unstructured":"Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V, Caligaris-Cappio F, Ghia P (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 112(1):188\u2013195. doi: 10.1182\/blood-2007-09-111344","journal-title":"Blood"},{"issue":"3","key":"2788_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","volume":"101","author":"S Lanham","year":"2003","unstructured":"Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G (2003) Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 101(3):1087\u20131093. doi: 10.1182\/blood-2002-06-1822","journal-title":"Blood"},{"issue":"1","key":"2788_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2141.2009.08032.x","volume":"149","author":"F Morabito","year":"2010","unstructured":"Morabito F, Cutrona G, Gentile M, Fabbi M, Matis S, Colombo M, Reverberi D, Megna M, Spriano M, Callea V, Vigna E, Rossi E, Lucia E, Festini G, Zupo S, Molica S, Neri A, Ferrarini M (2010) Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL. Br J Haematol 149(1):160\u2013163. doi: 10.1111\/j.1365-2141.2009.08032.x","journal-title":"Br J Haematol"},{"issue":"1","key":"2788_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, Belhoul L, Stella S, Stavroyianni N, Crespo M, Hadzidimitriou A, Sutton L, Bosch F, Laoutaris N, Anagnostopoulos A, Montserrat E, Fassas A, Dighiero G, Caligaris-Cappio F, Merle-Beral H, Ghia P, Davi F (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109(1):259\u2013270. doi: 10.1182\/blood-2006-03-012948","journal-title":"Blood"},{"issue":"12","key":"2788_CR7","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1182\/blood-2003-12-4312","volume":"103","author":"FK Stevenson","year":"2004","unstructured":"Stevenson FK, Caligaris-Cappio F (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103(12):4389\u20134395. doi: 10.1182\/blood-2003-12-4312","journal-title":"Blood"},{"issue":"7","key":"2788_CR8","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","volume":"111","author":"A Lanemo Myhrinder","year":"2008","unstructured":"Lanemo Myhrinder A, Hellqvist E, Sidorova E, Soderberg A, Baxendale H, Dahle C, Willander K, Tobin G, Backman E, Soderberg O, Rosenquist R, Horkko S, Rosen A (2008) A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 111(7):3838\u20133848. doi: 10.1182\/blood-2007-11-125450","journal-title":"Blood"},{"issue":"4","key":"2788_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/imm.12285","volume":"142","author":"R Garcia-Munoz","year":"2014","unstructured":"Garcia-Munoz R, Llorente L (2014) Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms? Immunology 142(4):536\u2013550. doi: 10.1111\/imm.12285","journal-title":"Immunology"},{"issue":"1","key":"2788_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","volume":"210","author":"R Hoogeboom","year":"2013","unstructured":"Hoogeboom R, van Kessel KP, Hochstenbach F, Wormhoudt TA, Reinten RJ, Wagner K, Kater AP, Guikema JE, Bende RJ, van Noesel CJ (2013) A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. J Exp Med 210(1):59\u201370. doi: 10.1084\/jem.20121801","journal-title":"J Exp Med"},{"issue":"7415","key":"2788_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature11309","volume":"489","author":"M Duhren-Von Minden","year":"2012","unstructured":"Duhren-Von Minden M, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M, Hofmann D, Surova E, Follo M, Kohler F, Wardemann H, Zirlik K, Veelken H, Jumaa H (2012) Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489(7415):309\u2013312. doi: 10.1038\/nature11309","journal-title":"Nature"},{"issue":"10","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1182\/blood-2014-07-587790","volume":"125","author":"S Iacovelli","year":"2015","unstructured":"Iacovelli S, Hug E, Bennardo S, Duehren-Von Minden M, Gobessi S, Rinaldi A, Suljagic M, Bilbao D, Bolasco G, Eckl-Dorna J, Niederberger V, Autore F, Sica S, Laurenti L, Wang H, Cornall RJ, Clarke SH, Croce CM, Bertoni F, Jumaa H, Efremov DG (2015) Two types of BCR interactions are positively selected during leukemia development in the Emu-TCL1 transgenic mouse model of CLL. Blood 125(10):1578\u20131588. doi: 10.1182\/blood-2014-07-587790","journal-title":"Blood"},{"issue":"25","key":"2788_CR13","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","volume":"373","author":"JA Burger","year":"2015","unstructured":"Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Offner F, Mayer J, O\u2019Dwyer M, Hellmann A, Schuh A, Siddiqi T, Polliack A, Tam CS, Suri D, Cheng M, Clow F, Styles L, James DF, Kipps TJ, Investigators R (2015) Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia. N Engl J Med 373(25):2425\u20132437. doi: 10.1056\/NEJMoa1509388","journal-title":"N Engl J Med"},{"issue":"1","key":"2788_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, Grant B, Sharman JP, Coleman M, Wierda WG, Jones JA, Zhao W, Heerema NA, Johnson AJ, Sukbuntherng J, Chang BY, Clow F, Hedrick E, Buggy JJ, James DF, O\u2019Brien S (2013) Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 369(1):32\u201342. doi: 10.1056\/NEJMoa1215637","journal-title":"N Engl J Med"},{"issue":"2","key":"2788_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S1470-2045(15)00465-9","volume":"17","author":"A Chanan-Khan","year":"2016","unstructured":"Chanan-Khan A, Cramer P, Demirkan F, Fraser G, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Mato A, Pavlovsky MA, Karlsson C, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Hallek M, Investigators H (2016) Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Lancet Oncol 17(2):200\u2013211. doi: 10.1016\/S1470-2045(15)00465-9","journal-title":"Lancet Oncol"},{"issue":"13","key":"2788_CR16","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","volume":"115","author":"JW Friedberg","year":"2010","unstructured":"Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, Cripe LD, Gregory SA, Sterba MP, Lowe AM, Levy R, Shipp MA (2010) Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 115(13):2578\u20132585. doi: 10.1182\/blood-2009-08-236471","journal-title":"Blood"},{"issue":"9","key":"2788_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2012-08-452607","volume":"121","author":"JA Burger","year":"2013","unstructured":"Burger JA, Montserrat E (2013) Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling. Blood 121(9):1501\u20131509. doi: 10.1182\/blood-2012-08-452607","journal-title":"Blood"},{"issue":"20","key":"2788_CR18","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-15-0781","volume":"21","author":"SE Herman","year":"2015","unstructured":"Herman SE, Mustafa RZ, Jones J, Wong DH, Farooqui M, Wiestner A (2015) Treatment with ibrutinib inhibits BTK- and VLA-4-dependent adhesion of chronic lymphocytic leukemia cells in vivo. Clin Cancer Res 21(20):4642\u20134651. doi: 10.1158\/1078-0432.CCR-15-0781","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2788_CR19","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1182\/blood-2009-07-233692","volume":"115","author":"M Buchner","year":"2010","unstructured":"Buchner M, Baer C, Prinz G, Dierks C, Burger M, Zenz T, Stilgenbauer S, Jumaa H, Veelken H, Zirlik K (2010) Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia. Blood 115(22):4497\u20134506. doi: 10.1182\/blood-2009-07-233692","journal-title":"Blood"},{"issue":"5","key":"2788_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","volume":"114","author":"MP Quiroga","year":"2009","unstructured":"Quiroga MP, Balakrishnan K, Kurtova AV, Sivina M, Keating MJ, Wierda WG, Gandhi V, Burger JA (2009) B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. Blood 114(5):1029\u20131037. doi: 10.1182\/blood-2009-03-212837","journal-title":"Blood"},{"issue":"1","key":"2788_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11899-012-0147-9","volume":"8","author":"JR Brown","year":"2013","unstructured":"Brown JR (2013) Ibrutinib (PCI-32765), the first BTK (Bruton\u2019s tyrosine kinase) inhibitor in clinical trials. Curr Hematol Malig Rep 8(1):1\u20136. doi: 10.1007\/s11899-012-0147-9","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"2788_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","volume":"106","author":"M Burger","year":"2005","unstructured":"Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N, Kipps TJ, Burger JA (2005) Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 106(5):1824\u20131830. doi: 10.1182\/blood-2004-12-4918","journal-title":"Blood"},{"issue":"1","key":"2788_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.immuni.2006.11.012","volume":"26","author":"DJ Gorter de","year":"2007","unstructured":"de Gorter DJ, Beuling EA, Kersseboom R, Middendorp S, van Gils JM, Hendriks RW, Pals ST, Spaargaren M (2007) Bruton\u2019s tyrosine kinase and phospholipase Cgamma2 mediate chemokine-controlled B cell migration and homing. Immunity 26(1):93\u2013104. doi: 10.1016\/j.immuni.2006.11.012","journal-title":"Immunity"},{"key":"2788_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1476-4598-9-297","volume":"9","author":"J Catusse","year":"2010","unstructured":"Catusse J, Leick M, Groch M, Clark DJ, Buchner MV, Zirlik K, Burger M (2010) Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia. Mol Cancer 9:297. doi: 10.1186\/1476-4598-9-297","journal-title":"Mol Cancer"},{"issue":"3","key":"2788_CR25","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.3324\/haematol.2015.133470","volume":"101","author":"S Ganghammer","year":"2016","unstructured":"Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Johrer K, Wijtmans M, Leurs R, Smit MJ, Gattei V, Greil R, Hartmann TN (2016) Combined CXCR3\/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors. Haematologica 101(3):e99\u2013e102. doi: 10.3324\/haematol.2015.133470","journal-title":"Haematologica"},{"issue":"9","key":"2788_CR26","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.189.9.1461","volume":"189","author":"R Guinamard","year":"1999","unstructured":"Guinamard R, Signoret N, Ishiai M, Marsh M, Kurosaki T, Ravetch JV (1999) B cell antigen receptor engagement inhibits stromal cell-derived factor (SDF)-1alpha chemotaxis and promotes protein kinase C (PKC)-induced internalization of CXCR4. J Exp Med 189(9):1461\u20131466","journal-title":"J Exp Med"},{"issue":"6876","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/416094a","volume":"416","author":"K Reif","year":"2002","unstructured":"Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R, Cyster JG (2002) Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416(6876):94\u201399. doi: 10.1038\/416094a","journal-title":"Nature"},{"issue":"16","key":"2788_CR28","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1158\/0008-5472.CAN-08-4750","volume":"69","author":"A Vlad","year":"2009","unstructured":"Vlad A, Deglesne PA, Letestu R, Saint-Georges S, Chevallier N, Baran-Marszak F, Varin-Blank N, Ajchenbaum-Cymbalista F, Ledoux D (2009) Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease. Cancer Res 69(16):6387\u20136395. doi: 10.1158\/0008-5472.CAN-08-4750","journal-title":"Cancer Res"},{"key":"2788_CR29","doi-asserted-by":"publisher","unstructured":"Saint Georges S, Quettier M, Bouyaba M, Le Coquil S, Lauriente V, Guittat L, Levy V, Ajchenbaum-Cymbalista F, Varin-Blank N, Le Roy C, Ledoux D (2016) Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia. Oncotarget. doi: 10.18632\/oncotarget.9031","DOI":"10.18632\/oncotarget.9031"},{"issue":"7","key":"2788_CR30","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1158\/0008-5472.CAN-08-4136","volume":"69","author":"TN Hartmann","year":"2009","unstructured":"Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R (2009) Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res 69(7):3121\u20133130. doi: 10.1158\/0008-5472.CAN-08-4136","journal-title":"Cancer Res"},{"issue":"3","key":"2788_CR31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.1989.tb04290.x","volume":"71","author":"RJ Collins","year":"1989","unstructured":"Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol 71(3):343\u2013350","journal-title":"Br J Haematol"},{"issue":"17","key":"2788_CR32","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1073\/pnas.85.17.6493","volume":"85","author":"J Cambier","year":"1988","unstructured":"Cambier J, Chen ZZ, Pasternak J, Ransom J, Sandoval V, Pickles H (1988) Ligand-induced desensitization of B-cell membrane immunoglobulin-mediated Ca2+ mobilization and protein kinase C translocation. Proc Natl Acad Sci U S A 85(17):6493\u20136497","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2788_CR33","doi-asserted-by":"crossref","first-page":"8766","DOI":"10.1073\/pnas.87.22.8766","volume":"87","author":"GT Rijkers","year":"1990","unstructured":"Rijkers GT, Griffioen AW, Zegers BJ, Cambier JC (1990) Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95. Proc Natl Acad Sci U S A 87(22):8766\u20138770","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2788_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.imlet.2005.09.001","volume":"102","author":"R Geisberger","year":"2006","unstructured":"Geisberger R, Konigsberger S, Achatz G (2006) Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1. Immunol Lett 102(2):169\u2013176. doi: 10.1016\/j.imlet.2005.09.001","journal-title":"Immunol Lett"},{"issue":"1","key":"2788_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02183.x","volume":"116","author":"JV Stein","year":"2005","unstructured":"Stein JV, Nombela-Arrieta C (2005) Chemokine control of lymphocyte trafficking: a general overview. Immunology 116(1):1\u201312. doi: 10.1111\/j.1365-2567.2005.02183.x","journal-title":"Immunology"},{"issue":"2","key":"2788_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/0008-5472.CAN-12-2749","volume":"73","author":"T Girbl","year":"2013","unstructured":"Girbl T, Hinterseer E, Grossinger EM, Asslaber D, Oberascher K, Weiss L, Hauser-Kronberger C, Neureiter D, Kerschbaum H, Naor D, Alon R, Greil R, Hartmann TN (2013) CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility. Cancer Res 73(2):561\u2013570. doi: 10.1158\/0008-5472.CAN-12-2749","journal-title":"Cancer Res"},{"issue":"8","key":"2788_CR37","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","volume":"99","author":"KJ Till","year":"2002","unstructured":"Till KJ, Lin K, Zuzel M, Cawley JC (2002) The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99(8):2977\u20132984","journal-title":"Blood"},{"issue":"1","key":"2788_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2015-02-626846","volume":"126","author":"TM Liu","year":"2015","unstructured":"Liu TM, Woyach JA, Zhong Y, Lozanski A, Lozanski G, Dong S, Strattan E, Lehman A, Zhang X, Jones JA, Flynn J, Andritsos LA, Maddocks K, Jaglowski SM, Blum KA, Byrd JC, Dubovsky JA, Johnson AJ (2015) Hypermorphic mutation of phospholipase C, gamma2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation. Blood 126(1):61\u201368. doi: 10.1182\/blood-2015-02-626846","journal-title":"Blood"},{"issue":"24","key":"2788_CR39","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","volume":"370","author":"JA Woyach","year":"2014","unstructured":"Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC (2014) Resistance mechanisms for the Bruton\u2019s tyrosine kinase inhibitor ibrutinib. N Engl J Med 370(24):2286\u20132294. doi: 10.1056\/NEJMoa1400029","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2788-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:02:53Z","timestamp":1498323773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2788-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}